P38 MAP kinase inhibitors
Abstract:
There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0